Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Other Working Capital Changes (2017 - 2021)

Cogent Biosciences has reported Other Working Capital Changes over the past 5 years, most recently at -$1.8 million for Q4 2021.

  • Quarterly results put Other Working Capital Changes at -$1.8 million for Q4 2021, up 43.4% from a year ago — trailing twelve months through Dec 2021 was $227000.0 (up 153.16% YoY), and the annual figure for FY2025 was $195000.0, up 114.07%.
  • Other Working Capital Changes for Q4 2021 was -$1.8 million at Cogent Biosciences, down from $1.5 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for COGT hit a ceiling of $3.2 million in Q3 2020 and a floor of -$3.2 million in Q4 2020.
  • Median Other Working Capital Changes over the past 5 years was -$27000.0 (2019), compared with a mean of $25000.0.
  • Peak annual rise in Other Working Capital Changes hit 11937.04% in 2020, while the deepest fall reached 6422.45% in 2020.
  • Cogent Biosciences' Other Working Capital Changes stood at -$5000.0 in 2017, then plummeted by 4160.0% to -$213000.0 in 2018, then soared by 77.0% to -$49000.0 in 2019, then tumbled by 6422.45% to -$3.2 million in 2020, then skyrocketed by 43.4% to -$1.8 million in 2021.
  • The last three reported values for Other Working Capital Changes were -$1.8 million (Q4 2021), $1.5 million (Q3 2021), and $1.9 million (Q2 2021) per Business Quant data.